Original ArticlePharmacognosy ResearchVol. 13 | Issue 2 | 2021 | pp. 96–103Open access
Herbs and Medications Used for Treatment and Prophylaxis of Influenza Infections Including H5N1, H1N1, SARS‑CoV, and SARS‑CoV‑2
- 1,2*
- 1 Clinical Pharmacy Specialist at Sameh Pharmacy, Cairo, EGYPT.
- 2 Former Hospital Pharmacist at Gizan General Hospital, KSA, SAUDI ARABIA.
Published in Pharmacognosy Research
Correspondence: Sameh Monir Abdou Desouki
Clinical Pharmacy Specialist at Sameh Pharmacy, Cairo, EGYPT.; Former Hospital Pharmacist at Gizan General Hospital, KSA, SAUDI ARABIA.
Email: sammon2002@yahoo.com
Copyright: © 2021 Manuscript Technomedia. This is an open access article.
- Published:
- May 29, 2021
- Received:
- May 29, 2020
- Accepted:
- Feb 23, 2021
- DOI:
- 10.4103/pr.pr_32_20
How to cite
Desouki, S. M. A. (2021). Herbs and Medications Used for Treatment and Prophylaxis of Influenza Infections Including H5N1, H1N1, SARS‑CoV, and SARS‑CoV‑2. Pharmacognosy Research, 13(2), 96–103. https://doi.org/10.4103/pr.pr_32_20
Abstract
Background: Herbs are plants or plant parts used for their scent, flavor, or therapeutic properties. Herbal medicine is one type of dietary supplement that has been used for thousands of years for treatment or prophylaxis of many diseases including influenza virus infection. Although there are many previous studies about these issues, I did not find many research about using these herbs in treatment or prophylaxis of other influenza infections including H5N1, H1N1, severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2. Objective: To collect, evaluate, and explore new important data about using medicinal herbs in these disorders' treatment or prophylaxis. Materials and Methods: I collected and explored new results and data from 24 professional health-care givers who had an experience about using these herbs in treatment or prophylaxis of these diseases. Then, I evaluated descriptively and quantitatively the results with alpha significance level ≤5% by tests such as Chi-square one-sample and reliability and validity tests. Results: The study showed many significant results about using these herbs, through using descriptive tests including one-sample Chi-square test, like in SARS-CoV-2 treatment (n = 414) with mean = 2.5870 ± 0.06730 and P < 0.05, while in SARS-CoV-2, prophylaxis (n = 275) with mean = 2.1164 ± 0.06271 and P < 0.05. Conclusion: This study revealed that there are some particular herbs that can be used in the treatment and prophylaxis of these diseases as adjunctives to the main typical treatment regimen, not as a monotherapy. Furthermore, many studies should be conducted in this field.
Keywords
Subject
Article metadata
| Title | Herbs and Medications Used for Treatment and Prophylaxis of Influenza Infections Including H5N1, H1N1, SARS‑CoV, and SARS‑CoV‑2 |
|---|---|
| Authors | Sameh Monir Abdou Desouki |
| Affiliations | Clinical Pharmacy Specialist at Sameh Pharmacy, Cairo, EGYPT.; Former Hospital Pharmacist at Gizan General Hospital, KSA, SAUDI ARABIA. |
| Corresponding author | sammon2002@yahoo.com |
| Journal | Pharmacognosy Research |
| Volume / Issue | Vol. 13, Issue 2 (2021) |
Also in this issue
- Foliar Epidermal Study on Selected Medicinal Plants Used in Homeopathypp. 75–81
- Leaf Extracts of Glyphaea brevis Attenuate High Blood Glucose and Lipids in Diabetic Rats Induced with Streptozotocinpp. 82–88
- Isolation, Characterization, and Optimization of Protease‑Producing Bacterium Bacillus thuringiensis from Paddy Field Soilpp. 89–95
Readers Also Viewed
Effect of the Fractions of Coccinia grandis on Ethanol- Induced Cerebral Oxidative Stress in Rats
M. Umamaheswari, T. K. Chatterjee
Jan 1, 2009
Phytochemical Screening and Antioxidant Activity Evaluation of Selected Philippine Fruit Peels and Pulps
Mildred Dagcuta Pates, Angelo Mark Po Walag, Romeo M. Del Rosario
Aug 17, 2026
Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Review
Jehath Syed, Christy Thomas, Bavneet Kaur
Oct 23, 2026